Trial Profile
A retrospective trial to assess incobotulinumtoxinA in patients who switched from treatment with onabotulinumtoxinA
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Sep 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Blepharospasm; Dystonia; Hemifacial spasm; Hyperhidrosis; Migraine; Torticollis
- Focus Adverse reactions; Therapeutic Use
- 13 Sep 2015 New trial record
- 18 Jun 2015 Results presented at the 19th International Congress of Parkinson's Disease and Movement Disorders.